When was dasatinib launched?

Dasatinib was approved for marketing by the U.S.FDA in2006 and in my country in2011. DasatinibIndicated for the treatment of adults with newly diagnosed Philadelphia chromosome-positive (Ph+)chronic myelogenous leukemia(CML)chronic phase. Treatment of adults with chronic, accelerated, or myeloid or lymphoblastic phase Ph+ CML who are resistant or intolerant to prior therapy (including imatinib). Adults with Philadelphia chromosome-positive acute lymphoblastic leukemia(Ph+ ALL) who are resistant or intolerant to previous treatments. It is used to treat pediatric patients aged 1 and above in the chronic phase of Ph+ CML. It is used to treat pediatric patients 1 years old and above who are newly diagnosed with Ph+ ALL and receive chemotherapy.

Dasatinib belongs to the kinase inhibitor class of drugs. Dasatinib blocks the activity of an abnormal protein that is a signal for cancer cell reproduction. Many drugs can interact with dasatinib, and some drugs should not be used together. Tell your doctor about all the medicines you currently take and any medicines you start or stop using. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Sometimes it is unsafe to use certain drugs together. Some drugs can affect the blood levels of other drugs you take, which may increase side effects or make the drugs less effective. If you want to get more high-quality information, you can contact Yaode, and Yaode will do its best to learn more about high-quality overseas drugs for you.

xa0